-DOCSTART- -X- O
Infectious -X- _ O
diseases -X- _ O
and -X- _ O
cancers -X- _ O
are -X- _ O
some -X- _ O
of -X- _ O
the -X- _ O
commonest -X- _ O
causes -X- _ O
of -X- _ O
deaths -X- _ O
throughout -X- _ O
the -X- _ O
world. -X- _ O
The -X- _ O
previous -X- _ O
two -X- _ O
decades -X- _ O
have -X- _ O
witnessed -X- _ O
a -X- _ O
combined -X- _ O
endeavor -X- _ O
across -X- _ O
various -X- _ O
biological -X- _ O
sciences -X- _ O
to -X- _ O
address -X- _ O
this -X- _ O
issue -X- _ O
in -X- _ O
novel -X- _ O
ways. -X- _ O
The -X- _ O
advent -X- _ O
of -X- _ O
recombinant -X- _ O
DNA -X- _ O
technologies -X- _ O
has -X- _ O
provided -X- _ O
the -X- _ O
tools -X- _ O
for -X- _ O
producing -X- _ O
recombinant -X- _ B-Intervention
proteins -X- _ I-Intervention
that -X- _ O
can -X- _ O
be -X- _ O
used -X- _ O
as -X- _ O
therapeutic -X- _ O
agents. -X- _ O
A -X- _ O
number -X- _ O
of -X- _ O
expression -X- _ O
systems -X- _ O
have -X- _ O
been -X- _ O
developed -X- _ O
for -X- _ O
the -X- _ O
production -X- _ O
of -X- _ O
pharmaceutical -X- _ O
products. -X- _ O
Recently -X- _ O
, -X- _ O
advances -X- _ O
have -X- _ O
been -X- _ O
made -X- _ O
using -X- _ B-Outcome
plants -X- _ I-Outcome
as -X- _ I-Outcome
bioreactors -X- _ I-Outcome
to -X- _ I-Outcome
produce -X- _ I-Outcome
therapeutic -X- _ I-Outcome
proteins -X- _ I-Outcome
directed -X- _ I-Outcome
against -X- _ I-Outcome
infectious -X- _ I-Outcome
diseases -X- _ I-Outcome
and -X- _ I-Outcome
cancers. -X- _ I-Outcome
This -X- _ O
review -X- _ O
highlights -X- _ O
the -X- _ O
recent -X- _ O
progress -X- _ O
in -X- _ O
therapeutic -X- _ B-Intervention
protein -X- _ I-Intervention
expression -X- _ I-Intervention
in -X- _ I-Intervention
plants -X- _ I-Intervention
( -X- _ O
stable -X- _ O
and -X- _ O
transient -X- _ O
) -X- _ O
, -X- _ O
the -X- _ O
factors -X- _ O
affecting -X- _ O
heterologous -X- _ O
protein -X- _ O
expression -X- _ O
, -X- _ O
vector -X- _ O
systems -X- _ O
and -X- _ O
recent -X- _ O
developments -X- _ O
in -X- _ O
existing -X- _ O
technologies -X- _ O
and -X- _ O
steps -X- _ O
towards -X- _ O
the -X- _ O
industrial -X- _ O
production -X- _ O
of -X- _ O
plant-made -X- _ O
vaccines -X- _ O
, -X- _ O
antibodies -X- _ O
, -X- _ O
and -X- _ O
biopharmaceuticals -X- _ O
. -X- _ O

